AI in Oncology Market to Grow with a CAGR of 9.43% through 2030F

Increasing awareness of the importance of early cancer detection is expected to drive the Global AI in Oncology Market growth in the forecast period, 2026-2030

According to TechSci Research report, “AI in Oncology Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, the Global AI in Oncology Market stood at USD 701.08 Million in 2024 and is anticipated to grow with a CAGR of 9.43% in the forecast period. The growth of the AI in oncology market is attributed to the increasing prevalence of cancer, technological advancement in cancer diagnostics and healthcare infrastructure, and increasing demand for early and accurate diagnosis of cancer.  The rising initiatives undertaken by public and private organizations to invest in R&D for the introduction of novel technologies are further anticipated to fuel the growth of the market. 

COVID-19 pandemic had a positive impact on the market as it significantly increased the demand for the utilization of AI in oncology as restrictions over movement were imposed globally in hospitals and homecare settings. Due to lockdown and travel restrictions, patients’ diagnosis, care, and treatment were some of the major challenges as a result of which the need to develop products that can help in providing solutions in remote locations and at an early stage significantly increased. Due to a shortage of medical professionals, the use of AI has grown even more to provide better results to patients.  

One of the key factors responsible for the exponential growth of the overall market is the increasing prevalence of cancer globally. The rising prevalence of cancer and the shortages of healthcare professionals is propelling the adoption of AI to meet the rising demand for novel solutions to provide efficient and accurate diagnosis and treatment. Technological advancements and the incorporation of AI in applications such as classification, detection, segmentation, characterization, and monitoring are fueling the growth of the market. Government and private investment in the field of oncology for the adoption of artificial intelligence is enhancing the diagnostic and therapeutic scenario of providing efficient oncological solutions.

The Global AI in Oncology Market is segmented into component, cancer type, treatment type, regional distribution, and company

Based on treatment type, chemotherapy segment is expected to grow during the forecast period. Chemotherapy is a commonly used cancer treatment procedure, according to the American Cancer Society an estimated 60% of patients with Stage 4 bladder cancer receive chemotherapy. AI integration in chemotherapy treatment aids healthcare professionals in developing a personalized digital profile of patients, allowing their dose to be tailored during treatment. Increased research activities for incorporating AI into chemotherapy accelerate segment growth. The incorporation of AI to provide tailored chemotherapy with reduced dosage and fewer side effects enhances the adoption of chemotherapy.

Based on region, Asia-Pacific is the fastest-growing region in the global AI in oncology market due to several key factors. The region is witnessing a sharp rise in cancer incidence, creating an urgent need for advanced diagnostic and treatment technologies. Governments and healthcare providers across countries like China, Japan, India, and South Korea are increasingly investing in AI-driven healthcare infrastructure. Supportive regulatory policies, growing digitalization, and the expansion of telemedicine are further accelerating AI adoption. The presence of a large patient population generates vast datasets, which are essential for training effective AI models. Collaborations between local tech firms, hospitals, and global AI leaders are also driving innovation. These combined elements are propelling rapid advancements and positioning Asia-Pacific as a hub for AI in oncology.

Major companies operating in Global AI in Oncology Market are:

·         Azra AI.

·         IBM

·         Siemens Healthcare GmbH.

·         Intel Corporation.

·         GE HealthCare.

·         NVIDIA Corporation.

·         Digital Diagnostics Inc.

·         ConcertAI.

·         Median Technologies.

Download Free Sample Report

Customers can also request for 10% free customization on this report

“Advancement of technology and the use of AI in cancer diagnostics drive the expansion of the healthcare industry. The artificial tools require low-cost diagnostic processes and quick detection data reporting. The demand for technological advancements in the healthcare field for cancer detection and screening is also expected to boost industry growth. Government spending on healthcare technology drives the expansion of the healthcare fields in emerging nations. The increasing awareness of the importance of early cancer detection drives the advancement of Artificial intelligence and machine learning in cancer diagnostics. The increase in the number of government programs encourages healthcare organizations and providers to integrate AI tools in their hospitals for the betterment and advancement of patient therapy” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“AI in Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component (Software Solutions, Hardware, Services), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others), By Treatment Type (Chemotherapy, Radiotherapy, Immunotherapy, Others), By Region & Competition, 2020-2030F”, has evaluated the future growth potential of Global AI in Oncology Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global AI in Oncology Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com